AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gedopan I/V Injection

Prescription Icon
Prescription Required

Marketer

Anevay Pharmaceuticals Pvt. Ltd.

Salt Composition

Pantoprazole (40mg)

Overview Gedopan I/V Injection

Intravenous Gedopan reduces stomach acid production. It treats acid-related conditions affecting the stomach and intestines, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and promoting healing. This medication, a proton pump inhibitor (PPI), also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Administered intravenously by a healthcare provider, it's prescribed only when deemed superior to oral forms by your physician. Dosage and treatment duration are determined individually based on your condition and response. Consistent use as directed is crucial, even with rapid symptom resolution. Dietary modifications—smaller, more frequent meals, avoidance of caffeine, spicy, and fatty foods—can enhance treatment effectiveness. Common, generally mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or with high doses, may raise bone fracture risk. Discuss bone health maintenance, such as calcium and vitamin D supplementation, with your doctor. Gedopan I/V is contraindicated in individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding individuals should seek medical counsel before use. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.

Uses of Gedopan I/V Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Gedopan I/V Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

Common Side effects of Gedopan I/V Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Gedopan I/V Injection:

This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.

How Gedopan I/V Injection works:

Pantoprazole intravenous injection decreases gastric acid production, thereby alleviating heartburn and acid indigestion. It belongs to the proton pump inhibitor (PPI) class of medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while receiving Gedopan I/V Injection.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Gedopan I/V Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Intravenous Gedopan administration during lactation appears to pose minimal risk to the infant, based on currently available, albeit limited, human data.

DrivingDrivingCONSULT YOUR DOCTOR

Gedopan I/V Injection's effect on driving ability is unknown. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Intravenous Gedopan administration is considered safe for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Intravenous Gedopan administration requires careful consideration in patients exhibiting severe hepatic impairment. Dosage modification for Gedopan intravenous injection may be necessary. Physician consultation is advised.

What if you forget to take Gedopan I/V Injection :

Omitting a scheduled dose of Gedopan I/V Injection necessitates contacting your physician.

Facts to Know About Gedopan I/V Injection

LabelValue
Type of Compound Benzimidazole sulfone compound
Potential for Dependence None.
Type of Medication Stomach and intestinal
Mechanism of Action Gastric acid secretion suppressants

FAQs on Gedopan I/V Injection

Intravenous Gedopan is indicated for peptic ulcer management, reflux esophagitis, and gastroesophageal reflux disease (GERD). This injection counteracts painkiller-induced hyperacidity. Furthermore, it treats Zollinger-Ellison syndrome (ZES), a condition characterized by excessive gastric acid secretion. Its mechanism involves decreasing stomach acid production, thereby alleviating symptoms.
Concurrent administration of antacids and Gedopan I/V Injection is permissible, provided there's a two-hour interval between their respective administrations.
Improvement should be noticeable within 2 to 3 days. However, Gedopan I/V Injection may require up to 4 weeks to fully take effect, meaning some symptoms could persist.
Infrequent, yet possible, weight increase may occur with prolonged intravenous Gedopan administration. This may be attributed to improved reflux symptoms leading to increased food intake. Discuss any weight concerns with your physician.
Consumption of alcohol is not recommended with Gedopan I/V Injection. While alcohol doesn't directly interfere with Gedopan I/V Injection's mechanism, it can elevate stomach acid levels, potentially exacerbating your condition.
Administer Gedopan I/V Injection one hour prior to eating. Consumption of spicy or high-fat foods should be avoided during treatment. Similarly, refrain from beverages containing caffeine, including tea, coffee, and cola. Alcoholic drinks should also be omitted, as they could exacerbate your condition.
Intravenous Gedopan is typically indicated for brief treatment periods. Nevertheless, in specific conditions like peptic ulcers or Zollinger-Ellison syndrome, prolonged administration may be necessary. Extended use, however, elevates the potential for adverse reactions and warrants careful monitoring by a physician. Always adhere to your doctor's instructions and remain under their care when using intravenous Gedopan.
Concurrent use of analgesics and Gedopan I/V Injection is considered safe. Gedopan I/V Injection acts as a preventative measure against the gastrointestinal distress, including ulcers, that can be a side effect of painkiller use. Administer Gedopan I/V Injection one hour prior to meals, while analgesics are typically best consumed with or after food to minimize stomach irritation.
A single dose of Gedopan I/V Injection might not provide adequate relief. Symptom improvement is often seen with just a few doses. Generally, Gedopan I/V Injection is used short-term, up to two weeks, for conditions like heartburn, indigestion, and acid reflux. Longer-term treatment with Gedopan I/V Injection may be necessary in cases such as peptic ulcer disease and Zollinger-Ellison syndrome (ZES), as determined by your physician. If symptoms persist after two weeks of regular use as directed, seek medical advice.
Prolonged Gedopan I/V Injection use exceeding three months can result in adverse effects. Low blood magnesium is a primary concern, potentially causing fatigue, confusion, dizziness, tremors, and muscle spasms, alongside irregular heartbeat. Treatment extending beyond one year increases the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can lead to anemia, manifesting as increased fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, digestive upset, anorexia, flatulence, and neurological symptoms including numbness, paresthesia, and gait disturbances.
Gedopan I/V Injection
37
MRP 45
17% off